Administration To Loan Kodak $765M To Make Generic Drug Ingredients

The Trump administration is poised to loan Kodak Pharmaceuticals $765 million to domestically produce generic drug ingredients, and the goal is for the company to make 25% of active pharmaceutical ingredients used in the U.S. generic market. The initiative aims to avert shortages of generic drugs due to supply chain issues that the U.S. government has little control over because most generic drug ingredients are made in China and India. The pandemic exacerbated shortages of injectible generics that hospitals have...